Gary A. Rosenberg mainly focuses on Matrix metalloproteinase, Blood–brain barrier, Pathology, Neuroinflammation and Ischemia. His Matrix metalloproteinase study integrates concerns from other disciplines, such as Angiogenesis, Proteases, Cerebral edema, Neuroscience and Cell biology. His Proteases study combines topics from a wide range of disciplines, such as Extracellular and Extracellular matrix.
His Blood–brain barrier study deals with the bigger picture of Internal medicine. His research integrates issues of Matrix metalloproteinase inhibitor, Vascular disease and Edema in his study of Pathology. His Ischemia study incorporates themes from Stroke, Cerebral infarction, Programmed cell death and Neuroprotection.
His scientific interests lie mostly in Pathology, Social work, Matrix metalloproteinase, Blood–brain barrier and White matter. The various areas that he examines in his Pathology study include Stroke, Internal medicine, Vascular disease, Ischemia and Magnetic resonance imaging. His Social work research is multidisciplinary, incorporating elements of Social psychology, Health care, Nursing, Applied psychology and Public relations.
His study in Matrix metalloproteinase is interdisciplinary in nature, drawing from both Proteases, Neuroinflammation, Extracellular matrix, Cell biology and Programmed cell death. His research investigates the connection between Extracellular matrix and topics such as Basal lamina that intersect with problems in Collagenase. The Blood–brain barrier study combines topics in areas such as Gelatinase A, Cerebrospinal fluid, Immunology and Vascular permeability.
His primary areas of study are Pathology, White matter, Blood–brain barrier, Dementia and Vascular disease. His work in Pathology tackles topics such as Stroke which are related to areas like Ischemia, Pharmacology and Neuroprotection. His research integrates issues of Anesthesia, Multiple sclerosis, Leukoencephalopathy and Choroid plexus in his study of Blood–brain barrier.
His Dementia study incorporates themes from Alzheimer's disease, Magnetic resonance imaging and Clinical trial. In most of his Neuroinflammation studies, his work intersects topics such as Matrix metalloproteinase. His Matrix metalloproteinase research integrates issues from Angiogenesis and Cell biology.
Gary A. Rosenberg mainly investigates Pathology, White matter, Dementia, Blood–brain barrier and Vascular disease. His Pathology research is multidisciplinary, incorporating perspectives in Stroke and Neurology. Gary A. Rosenberg combines subjects such as Internal medicine, Hypoxia, Hyperintensity and Morris water navigation task with his study of White matter.
The various areas that Gary A. Rosenberg examines in his Dementia study include Alzheimer's disease and Neuroimaging. His studies in Blood–brain barrier integrate themes in fields like Multiple sclerosis, Angiogenesis and Matrix metalloproteinase. He interconnects Ischemia and Cell biology in the investigation of issues within Matrix metalloproteinase.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards
Vladimir Hachinski;Costantino Iadecola;Ron C. Petersen;Monique M. Breteler.
Stroke (2006)
Collagenase-induced intracerebral hemorrhage in rats.
G A Rosenberg;S Mun-Bryce;M Wesley;M Kornfeld.
Stroke (1990)
Matrix Metalloproteinases and TIMPs Are Associated With Blood-Brain Barrier Opening After Reperfusion in Rat Brain
G. A. Rosenberg;E. Y. Estrada;J. E. Dencoff.
Stroke (1998)
Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat
Yi Yang;Eduardo Y Estrada;Jeffrey F Thompson;Wenlan Liu.
Journal of Cerebral Blood Flow and Metabolism (2007)
Matrix metalloproteinases in neuroinflammation
Gary A. Rosenberg.
Glia (2002)
Blood–Brain Barrier Breakdown in Acute and Chronic Cerebrovascular Disease
Yi Yang;Gary A. Rosenberg.
Stroke (2011)
Matrix Metalloproteinases and Their Multiple Roles in Neurodegenerative Diseases
Gary A Rosenberg.
Lancet Neurology (2009)
Cortical spreading depression activates and upregulates MMP-9
Yasemin Gursoy-Ozdemir;Jianhua Qiu;Norihiro Matsuoka;Hayrunnisa Bolay.
Journal of Clinical Investigation (2004)
Proteolytic cascade enzymes increase in focal cerebral ischemia in rat.
Gary A. Rosenberg;Gary A. Rosenberg;Milo Navratil;Frank Barone;Giora Feuerstein.
Journal of Cerebral Blood Flow and Metabolism (1996)
Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia.
E. Candelario-Jalil;Y. Yang;G.A. Rosenberg.
Neuroscience (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Mind Research Network
KU Leuven
University of Gothenburg
Forschungszentrum Jülich
Georgia State University
New York University
Cornell University
University of Iowa
Ludwig-Maximilians-Universität München
National Institutes of Health
University College London
University of Augsburg
South China University of Technology
Michigan State University
Scottish Association For Marine Science
University of Malaga
Tohoku University
Ulsan National Institute of Science and Technology
Institute for Advanced Sustainability Studies
National Institutes of Health
University of California, Irvine
Brigham and Women's Hospital
University of California, Los Angeles
Boston University
Antoni van Leeuwenhoek Hospital
McMaster University